The 3rd Annual Meeting of the International Academy for Clinical Hematology IACH: Focus on Leukemia, October 1-3, 2020, saw the discussion of key updates in the hemonc field with a focus on leukemia.

Highlights from this year’s IACH Annual Meeting include management of elderly leukemia, CAR T-cell therapy, rare leukemias as well as novel drugs.

View all videos

IACH Focus on Leukemia 2020

01–03 October 2020 | Nice, France

First results of the 2nd H2H of iBTKs: the ALPINE study. With a 15 months follow up.
So different population from ELEVATE RR #iwCLL2021 @PeterHillmen #CLL

4

⭐@ninashah33 of @UofCalifornia gives us all the latest developments on the use of alloCAR-T therapies ⭐

Watch: 👉http://ow.ly/k1V050G7DAQ👈

@SocietyofHemOnc #SOHO2021 #HemOnc #ImmunoOnc #CART #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?

Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021

Load More...

IACH Focus on Leukemia 2020

01–03 October 2020 | Nice, France

The 3rd Annual Meeting of the International Academy for Clinical Hematology IACH: Focus on Leukemia, October 1-3, 2020, saw the discussion of key updates in the hemonc field with a focus on leukemia.

Highlights from this year’s IACH Annual Meeting include management of elderly leukemia, CAR T-cell therapy, rare leukemias as well as novel drugs.

View all videos

First results of the 2nd H2H of iBTKs: the ALPINE study. With a 15 months follow up.
So different population from ELEVATE RR #iwCLL2021 @PeterHillmen #CLL

4

⭐@ninashah33 of @UofCalifornia gives us all the latest developments on the use of alloCAR-T therapies ⭐

Watch: 👉http://ow.ly/k1V050G7DAQ👈

@SocietyofHemOnc #SOHO2021 #HemOnc #ImmunoOnc #CART #BloodCancerAwarenessMonth #CancelBloodCancer #BCAM

In advance of our 2nd debate at #iwCLL2021 between Peter Dreger and @drjgauthier, which type of cellular therapy do you prefer for your patients with CLL?

Very nice description of a very difficult clinical situation: Richter’s Transformation with CNS involvement. Presented by @YucaiWangMD @WeiDing3 at #iwCLL2021

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter